[1] ROBERT S, GICQUEL T, VICTONI T, et al. Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis. Biosci Rep, 2016,36(4):e00360.
[2] WAGSTAFF L, KELWICK R, DECOCK J, et al. The roles of ADAMTS metalloproteinases in tumorigenesis and metastasis. Front Biosci (Landmark Ed), 2011,16(5):1861-1872.
[3] PORTER S, CLARK I M, KEVORKIAN L, et al. The ADAMTS metalloproteinases. Biochem J, 2005,386(Pt 1):15-27.
[4] NICHOLSON A C, MALIK S B, LOGSDON J M J R, et al. Functional evolution of ADAMTS genes: evidence from analyses of phylogeny and gene organization. BMC Evol Biol, 2005,5:11.
[5] GLASSON S S, ASKEW R, SHEPPARD B, et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature, 2005,434(7033):644-648.
[6] COLIGE A, LI S W, SIERON A L, et al. cDNA cloning and expression of bovine procollagen I N-proteinase: a new member of the superfamily of zinc-metalloproteinases with binding sites for cells and other matrix components. Proc Natl Acad Sci USA, 1997,94(6):2374-2379.
[7] WANG W M, LEE S, STEIGLITZ B M, et al. Transforming growth factor-beta induces secretion of activated ADAMTS-2. A procollagen III N-proteinase. J Biol Chem, 2003,278(21):19549-19557.
[8] FERNANDES R J, HIROHATA S, ENGLE J M, et al. Procollagen II amino propeptide processing by ADAMTS-3. Insights on dermatosparaxis. J Biol Chem, 2001,276(34):31502-31509.
[9] SOEJIMA K, MATSUMOTO M, KOKAME K, et al. ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage. Blood, 2003,102(9):3232-3237.
[10] AL-AWADHI A, ADEKILE A, MAROUF R. Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait. J Thromb Thrombolysis, 2017,43(1):117-123.
[11] LIU C J, KONG W, ILALOV K, et al. ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein. FASEB J, 2006,20(7):988-990.
[12] OZLER S, OZTAS E, TOKMAK A, et al. Role of versican and ADAMTS-1 in polycystic ovary syndrome. J Clin Res Pediatr Endocrinol, 2017,9(1):24-30.
[13] ROCKS N, PAULISSEN G, QUESADA-CALVO F, et al. ADAMTS-1 metalloproteinase promotes tumor development through the induction of a stromal reaction in vivo. Cancer Res, 2008,68(22):9541-9550.
[14] DUBAIL J, KESTELOOT F, DEROANNE C, et al. ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity. Cell Mol Life Sci, 2010,67(24):4213-4232.
[15] ALPER M, AYDEMIR A T, KOCKAR F. Induction of human ADAMTS-2 gene expression by IL-1alpha is mediated by a multiple crosstalk of MEK/JNK and PI3K pathways in osteoblast like cells. Gene, 2015,573(2):321-327.
[16] OGINO H, HISANAGA A, KOHNO T, et al. Secreted metalloproteinase ADAMTS-3 inactivates reelin. J Neurosci, 2017,37(12):3181-3191.
[17] WAGSATER D, BJORK H, ZHU C, et al. ADAMTS-4 and -8 are inflammatory regulated enzymes expressed in macrophage-rich areas of human atherosclerotic plaques. Atherosclerosis, 2008,196(2):514-522.
[18] LEMARCHANT S, WOJCIECHOWSKI S, VIVIEN D, et al. ADAMTS-4 in central nervous system pathologies. J Neurosci Res, 2017,95(9):1703-1711.
[19] MILLER R E, TRAN P B, ISHIHARA S, et al. Therapeutic effects of an anti-ADAMTS-5 antibody on joint damage and mechanical allodynia in a murine model of osteoarthritis. Osteoarthritis Cartilage, 2016,24(2):299-306.
[20] DIDANGELOS A, MAYR U, MONACO C, et al. Novel role of ADAMTS-5 protein in proteoglycan turnover and lipoprotein retention in atherosclerosis. J Biol Chem, 2012,287(23):19341-19345.
[21] CAIN S A, MULARCZYK E J, SINGH M, et al. ADAMTS-10 and -6 differentially regulate cell-cell junctions and focal adhesions. Sci Rep, 2016,6:35956-35970.
[22] BUCKLAND J. Osteoarthritis: positive feedback between ADAMTS-7 and TNF in OA. Nat Rev Rheumatol, 2013,9(10):566-566.
[23] BAUER R C, TOHYAMA J, CUI J, et al. Knockout of Adamts7, a novel coronary artery disease locus in humans, reduces atherosclerosis in mice. Circulation, 2015,131(13):1202-1213.
[24] OCAK Z, ACAR M, GUNDUZ E, et al. Effect of hypericin on the ADAMTS-9 and ADAMTS-8 gene expression in MCF7 breast cancer cells. Eur Rev Med Pharmacol Sci, 2013,17(9):1185-1190.
[25] DUNN J R, REED J E, DU PLESSIS D G, et al. Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours. Br J Cancer, 2006,94(8):1186-1193.
[26] ARTUNC-ULKUMEN B, ULUCAY S, PALA H G, et al. Maternal serum ADAMTS-9 levels in gestational diabetes: a pilot study. J Matern Fetal Neonatal Med, 2017,30(12):1442-1445.
[27] WEI J, RICHBOURGH B, JIA T, et al. ADAMTS-12: a multifaced metalloproteinase in arthritis and inflammation. Mediators Inflamm, 2014,2014:649718.
[28] KASTRITIS E, PAPASSOTIRIOU I, TERPOS E, et al. Clinical and prognostic significance of serum levels of von Willebrand factor and ADAMTS-13 antigens in AL amyloidosis. Blood, 2016,128(3):405-409.
[29] LIU C, ZHAO L, ZHAO J, et al. Decreased ADAMTS-13 level is related to inflammation factors and risk stratification of acute lymphoblastic leukemia patients. Medicine (Baltimore), 2017,96(7):e6136.
[30] COLIGE A, VANDENBERGHE I, THIRY M, et al. Cloning and characterization of ADAMTS-14, a novel ADAMTS displaying high homology with ADAMTS-2 and ADAMTS-3. J Biol Chem, 2002,277(8):5756-5766.
[31] MOLOKWU C N, ADENIJI O O, CHANDRASEKHARAN S, et al. Androgen regulates ADAMTS15 gene expression in prostate cancer cells. Cancer Invest, 2010,28(7):698-710.
[32] KELWICK R, WAGSTAFF L, DECOCK J, et al. Metalloproteinase-dependent and -independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and metalloproteinase with thrombospondin motifs-15. Int J Cancer, 2015,136(4):14-26.
[33] GAO S, DE GEYTER C, KOSSOWSKA K, et al. FSH stimulates the expression of the ADAMTS-16 protease in mature human ovarian follicles. Mol Hum Reprod, 2007,13(7):465-471.
[34] MORALES J, AL-SHARIF L, KHALIL D S, et al. Homozygous mutations in ADAMTS10 and ADAMTS17 cause lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature. Am J Hum Genet, 2009,85(5):558-568.
[35] WEI J, LIU C J, LI Z. ADAMTS-18: a metalloproteinase with multiple functions. Front Biosci (Landmark Ed), 2014,19:1456-1467.
[36] KNAUFF E A, FRANKE L, VAN ES M A, et al. Genome-wide association study in premature ovarian failure patients suggests ADAMTS19 as a possible candidate gene. Hum Reprod, 2009,24(9):2372-2378.
[37] FILOU S, KORPETINOU A, KYRIAKOPOULOU D, et al. ADAMTS expression in colorectal cancer. PLoS One, 2015,10(3):e0121209.
[38] HANBY H A, ZHENG X L. Biochemistry and physiological functions of ADAMTS7 metalloprotease. Adv Biochem, 2013,1(3):43-50.
[39] ROCKS N, PAULISSEN G, EL HOUR M, et al. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie, 2008,90(2):369-379.
[40] CLISSA P B, LOPES-FERREIRA M, DELLA-CASA M S, et al. Importance of jararhagin disintegrin-like and cysteine-rich domains in the early events of local inflammatory response. Toxicon, 2006,47(5):591-596.
[41] TAKEDA S. ADAM and ADAMTS family proteins and snake venom metalloproteinases: a structural overview. Toxins (Basel), 2016,8(5):155-155.
[42] LIU C J, KONG W, ILALOV K, et al. ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein. FASEB J, 2006,20(7):988-990.
[43] KELWICK R, DESANLIS I, WHEELER G N, et al. The ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family. Genome Biol, 2015,16:113-128.
[44] LAI Y, BAI X, ZHAO Y, et al. ADAMTS-7 forms a positive feedback loop with TNF-alpha in the pathogenesis of osteoarthritis. Ann Rheum Dis, 2014,73(8):1575-1584.
[45] WANG L, WANG X, KONG W. ADAMTS-7, a novel proteolytic culprit in vascular remodeling. Acta Physiol Sin(生理学报),2010,62(4):285-294.
[46] DU Y, GAO C, LIU Z, et al. Upregulation of a disintegrin and metalloproteinase with thrombospondin motifs-7 by miR-29 repression mediates vascular smooth muscle calcification. Arterioscler Thromb Vasc Biol, 2012,32(11):2580-2588.
[47] JONSSON-RYLANDER A C, NILSSON T, FRITSCHE-DANIELSON R, et al. Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican. Arterioscler Thromb Vasc Biol, 2005,25(1):180-185.
[48] WANG L, ZHENG J, DU Y, et al. Cartilage oligomeric matrix protein maintains the contractile phenotype of vascular smooth muscle cells by interacting with alpha(7)beta(1) integrin. Circ Res, 2010,106(3):514-525.
[49] KESSLER T, ZHANG L, LIU Z, et al. ADAMTS-7 inhibits re-endothelialization of injured arteries and promotes vascular remodeling through cleavage of thrombospondin-1. Circulation, 2015,131(13):1191-1201.
[50] REILLY M P, LI M, HE J, et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet, 2011, 377(9763):383-392.
[51] FONTANIL T, RUA S, LLAMAZARES M, et al. Interaction between the ADAMTS-12 metalloprotease and fibulin-2 induces tumor-suppressive effects in breast cancer cells. Oncotarget, 2014,5(5):1253-1264.
[52] YOU L, TAN L, LIU L, et al. ADAMTS7 locus confers high cross-race risk for development of coronary atheromatous plaque. Mol Genet Genomics, 2016,291(1):121-128.
[53] YU J, ZHOU B, YU H, et al. Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease. Medicine (Baltimore), 2016,95(48): e5523.
[54] DU Y, WANG Y, WANG L, et al. Cartilage oligomeric matrix protein inhibits vascular smooth muscle calcification by interacting with bone morphogenetic protein-2. Circ Res, 2011,108(8):917-928.
[55] LIANG Y, FU Y, QI R M, et al. Cartilage oligomeric matrix protein is a natural inhibitor of thrombin. Blood, 2015,126(7):905-914.
[56] HUANG Y, XIA J, ZHENG J, et al. Deficiency of cartilage oligomeric matrix protein causes dilated cardiomyopathy. Basic Res Cardiol, 2013,108(5):374-394.
[57] WU W, ZHOU Y, LI Y, et al. Association between plasma ADAMTS-7 levels and ventricular remodeling in patients with acute myocardial infarction. Eur J Med Res, 2015,20:27.